Firefly Neuroscience (AIFF) stock surged over 20% pre-market after announcing a deal with the Department of War. The company will deploy its AI-powered EEG/ERP platform to assess and treat PTSD and traumatic brain injuries in service members and veterans, building on prior research with the US Naval Medical Center.